Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aeglea Biotherapeutics Inc (AGLE)
NASDAQ:AGLE
RESEARCH TOOLSreports
Holding AGLE?
Track your performance easily
Aeglea Biotherapeutics (AGLE) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
66.86% Other Institutional Investors
― ETFs
33.14% Public Companies and
Individual Investors
The ownership structure of Aeglea Biotherapeutics (AGLE) stock is a mix of institutional, retail, and individual investors. , and 33.14% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | xxxxxxxxxxxxx | $828651 | |
| Sep 30, 2023 | xxxxxxxxxxxxx | $993671 | |
| Sep 30, 2023 | xxxxxxxxxxxxx | $4635657 | |
| Sep 30, 2023 | xxxxxxxxxxxxx | $9810449 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aeglea Biotherapeutics Inc (AGLE)?
According to the latest TipRanks data, approximately 66.86% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 33.14% is held by retail investors.
What percentage of Aeglea Biotherapeutics Inc (AGLE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 66.86% of Aeglea Biotherapeutics Inc (AGLE) stock is held by institutional investors.
What percentage of Aeglea Biotherapeutics Inc (AGLE) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.14% of Aeglea Biotherapeutics Inc (AGLE) stock is held by retail investors.
Who owns the most shares of Aeglea Biotherapeutics Inc (AGLE)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.